Aussie pharmacy’s ‘freezing’ pills will be sold as a health product
More than 200 freezing pills sold as health products in the United States will be available as a supplement to the drugs used in the coronavirus pandemic.
Key points:Aussie pharmacy has been testing pills for a possible link to coronaviruses for more than a year and is now planning to offer the product nationallyA trial will be conducted to determine whether it can be a benefit for patients in the USA small group of volunteers will test freezing pill pills for coronaviral symptomsThe trial is expected to last for up to three monthsThe trial will test whether it is a benefit to patients in AmericaThe product is currently only available in Australia and is a small group in the world of pharmacology who are testing for coronovirus symptoms.
“This is a trial to determine if the freezing medicine can help people in the U.S. in the short-term,” Dr Paul Grafton, head of pharmacy at the Australian pharmacy, said in a statement.
“We hope to begin the trial this year and will continue to do so in the coming months.”
Dr Graftons trial will involve about 200 volunteers.
“It is expected that our study will take between three and four months to complete, and then we will test the products on the volunteers for coronivirus symptoms and to determine the effectiveness of the medicine,” he said.
“Once we have done that we will distribute it nationally in the form of a capsule, which is likely to be available in pharmacies.”
Mr Graftson said the freezers were made in Australia.
“The first batch was tested by a chemist in Australia, who found that the products were safe and effective,” he explained.
“However, we have since been testing the capsules in the USA to make sure they are as effective.”
The company is testing the products nationally, and will be offering them in stores for the first time later this year.
“These capsules will be tested for coronarides such as COVID-19, which includes the coroniviral syndrome, and we are testing them in the states of Minnesota and California,” Mr Graftoni said.
The company will be able to provide the capsules through a national distribution channel, with most of the capsules sold to the general public, but some will be delivered to health centres.
Dr Gost said that although freezers are “not an FDA-approved treatment, they are an important step in developing a safe, effective and safe-for-work product”.
“We believe that these products can help us better understand the effects of coronaviscosity, and can be used to reduce the risk of developing a coronavid infection.”
The product will be marketed to the Australian public through a number of online channels.
“Freezing pills will help patients get better and stay healthy by slowing the progression of coronoviral symptoms, including fever, cough and fatigue,” the company said.
“Freezers are also effective in preventing COVID and are safe for use.”
The company said there were a number other benefits for patients.
“There is a clear correlation between the presence of coronarids and poor health outcomes,” the statement said.